Breaking News Instant updates and real-time market news.

CVS

CVS Health

$69.92

0.39 (0.56%)

08:58
02/20/19
02/20
08:58
02/20/19
08:58

CVS says won't restart repurchases until reaching leverage target

Says won't restart repurchases, engage in large M&A until reaching leverage target.

  • 20

    Feb

  • 22

    Feb

  • 27

    Feb

CVS CVS Health
$69.92

0.39 (0.56%)

01/25/19
PIPR
01/25/19
NO CHANGE
PIPR
Report that CVS excluded Amgen's Aimovig 'greatly exaggerated,' says Piper
Piper Jaffray analyst Christopher Raymond kept an Overweight rating and $220 price target on Amgen (AMGN) following a Reuters report from earlier on Friday which stated that CVS (CVS) has excluded Amgen's Aimovig from its formulary. The analyst called the report "Friday afternoon clickbait" and noted that while CVS currently provides preferred status to Teva's (TEVA) Ajovy and Eli Lilly's (LLY) Emgality, this was made public in late 2018. In a check with management, Raymond found out the decision only encompasses about one-third of CVS network, that CVS is actively working to improve this access, and that 70% of commercial migraine patients have contracted access to Aimovig. Raymond concluded that this was "not something to worry about" in his view, and did not change his Q4, FY19, or FY20 estimates on Aimovig. In Friday trading, shares of Amgen were down just over 1% to $198.77.
01/28/19
CLVD
01/28/19
NO CHANGE
CLVD
CVS Health likely lost Coretrust contrac, says Cleveland Research
Cleveland Research said it is likely CVS Health lost the Coretrst contract to OptumRx, on top of the loss of BCBS of South Carolina to OptumRx.
01/31/19
MSCO
01/31/19
NO CHANGE
Target $391
MSCO
Overweight
Anthem price target raised to $391 from $372 at Morgan Stanley
Morgan Stanley analyst Zack Sopcak said Anthem's (ANTM) launch of IngenioRx three quarters early, giving it a presence in the 2020 selling season, leads him to see an increased likelihood of gaining share as compared to entry in the 2021 selling season when CVS Health (CVS) and Cigna (CI) would have more time for their marketing messages to mature post their respective mergers. While also noting that Anthem's 2019 guidance for EPS of $19+ came in well above estimates, Sopcak raised his price target on the stock to $391 from $372 and reiterated as a top pick with an Overweight rating.
02/07/19
MSCO
02/07/19
NO CHANGE
Target $100
MSCO
Overweight
CVS shares could rise 4%-9% on 'good enough' guidance, says Morgan Stanley
Morgan Stanley analyst Ricky Goldwasser noted that CVS Health will provide guidance on February 20 for the first time since completing the Aetna transaction and he puts 60% odds on initial FY19 EPS guidance of $7.00-$7.30. While such an outlook would be below the current consensus of $7.44, bears are concerned guidance could be below $7 and such an outlook would be seen as "good enough" to drive the stock up 4%-9%, Goldwasser tells investors. If initial 2019 EPS guidance is below $7.00, which is a scenario he gives a 30% probability, the stock could be down 11%. If the initial 2019 EPS guidance range has a midpoint above $7.40, which Goldwasser assigns only 10% odds of happening, the stock could be up 10%, the analyst said. He keeps an Overweight rating and $100 price target on CVS shares ahead of the company's December quarter earnings report.

TODAY'S FREE FLY STORIES

TELNY

Telenor

$0.00

(0.00%)

05:15
09/23/19
09/23
05:15
09/23/19
05:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANNSF

Aena

$0.00

(0.00%)

05:14
09/23/19
09/23
05:14
09/23/19
05:14
Downgrade
Aena rating change  »

Aena downgraded to Equal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$217.69

-3.22 (-1.46%)

05:13
09/23/19
09/23
05:13
09/23/19
05:13
Recommendations
Apple analyst commentary  »

Piper survey shows higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$154.45

-0.49 (-0.32%)

, ABT

Abbott

$83.56

0.35 (0.42%)

05:04
09/23/19
09/23
05:04
09/23/19
05:04
Recommendations
DexCom, Abbott analyst commentary  »

DexCom remains a…

DXCM

DexCom

$154.45

-0.49 (-0.32%)

ABT

Abbott

$83.56

0.35 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 16

    Oct

  • 13

    Nov

EW

Edwards Lifesciences

$219.56

4.45 (2.07%)

04:58
09/23/19
09/23
04:58
09/23/19
04:58
Initiation
Edwards Lifesciences initiated  »

Edwards Lifesciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

, HON

Honeywell

$168.42

1.7 (1.02%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Downgrade
Illinois Tool Works, Honeywell rating change  »

Illinois Tool Works…

ITW

Illinois Tool Works

$155.05

-0.91 (-0.58%)

HON

Honeywell

$168.42

1.7 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HR

Healthcare Realty Trust

$33.17

-0.155 (-0.47%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Healthcare Realty Trust management to meet with Capital One »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

NBIX

Neurocrine

$100.74

-0.77 (-0.76%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Neurocrine participates in a conference call with JPMorgan »

SMid Biotechnology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

SIBN

SI-Bone

$20.18

0.28 (1.41%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
SI-Bone management to meet with JMP Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

TXN

Texas Instruments

$126.70

-2.1 (-1.63%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Texas Instruments management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CLDR

Cloudera

$9.00

0.33 (3.81%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Cloudera management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 25

    Sep

IMAX

Imax

$21.83

0.04 (0.18%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Recommendations
Imax analyst commentary  »

Imax management to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Breaking General news story  »

6-Month Bill Auction to…

KNSL

Kinsale Capital Group

$99.46

-1.68 (-1.66%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Kinsale Capital Group management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 25

    Sep

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH â€' Level to be reported at 09:45 »

September PMI Composite…

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

HKMPY

Hikma

$0.00

(0.00%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Hikma participates in a conference call with JPMorgan »

European Pharma Equity…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 23

    Sep

  • 25

    Sep

DNOW

NOW Inc.

$12.05

-0.055 (-0.45%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
NOW Inc. management to meet with KeyBanc »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 06

    Nov

  • 11

    Nov

  • 12

    Nov

  • 13

    Nov

04:55
09/23/19
09/23
04:55
09/23/19
04:55
General news
Breaking General news story  »

3-Month Bill Auction to…

BRKR

Bruker

$43.62

0.06 (0.14%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Bruker management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

SPOT

Spotify

$120.73

-3.685 (-2.96%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Spotify management to meet with Morgan Stanley »

Group Breakfast Meeting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

WTTR

Select Energy Services

$9.02

0.11 (1.23%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Select Energy Services management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

PRGO

Perrigo

$55.29

0.995 (1.83%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Perrigo management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

  • 01

    Oct

ETSY

Etsy

$60.39

1.34 (2.27%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
Etsy management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

UPS

UPS

$120.71

1.61 (1.35%)

04:55
09/23/19
09/23
04:55
09/23/19
04:55
Conference/Events
UPS management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.